RxDoctor Payments Data

Mary-Laura Hohol, PA

Physician Assistant · Springfield, MANPI 1407165020

Payments from drug & device makers

$1,175in general payments, 2019–2025

Across 55 payments — averaging $21.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$550
  • Phathom Pharmaceuticals, Inc.$153
  • Takeda Pharmaceuticals U.S.A., Inc.$153
  • Johnson & Johnson$80
  • Bristol Myers Squibb$63
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$42
  • plus $133 from 6 others

What the payments were for

  • Food & beverage$1,16799%
  • Education$81%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,175 in reported general payments places this provider in the 85th percentile of 3,507 physician assistant providers in Massachusetts.

See all physician assistant providers in Massachusetts

Medicare billing

Part B allowed, 2024
$60,697
Medicare patients
485
Services billed
697

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide111$107,782
OcalivaObeticholic Acid11$105,021
CreonLipase/Protease/Amylase13$36,546
TrulancePlecanatide35$26,233
Mesalamine31$18,469
Omeprazole454$8,875
MotegrityPrucalopride Succinate12$5,786
Ursodiol17$4,669
Lubiprostone12$4,542
CholestyramineCholestyramine (With Sugar)34$3,682
Dicyclomine Hcl120$3,650
Sucralfate40$2,618
ClenpiqSod Picosulf/Mag Ox/Citric Ac15$2,609
Pantoprazole Sodium138$2,452
Hydrocortisone45$1,441

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess, Creon$550$144,328124 claims
Intercept Pharmaceuticals, Inc.Ocaliva$24$105,02111 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$42$26,23335 claims
Takeda Pharmaceuticals U.S.A., Inc.Motegrity$153$5,78612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,507 physician assistant providers in Massachusetts.

Other physician assistant in Springfield

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →